Skip to main content
. 2018 Sep 24;2018:5854710. doi: 10.1155/2018/5854710

Table 4.

Time course of urinary protein excretion (g per 24 h) in individual patients with RMN from entry into the study (baseline) to end of study (month 12).

Patient no. Primary IST Indication Baseline Month 3 Month 6 Month 12 Baseline to month 12 a
Urinary protein excretion Serum albumin urinary protein excretion Serum albumin urinary protein excretion Serum albumin urinary protein excretion Serum albumin urinary protein excretion Serum albumin
1 cCTX/GC Resistant 4.40 27.90 6.31 20.20 6.18 20.20 3.59 35.20 -0.81 7.30
2 CsA/GC Intolerant 5.60 22.50 2.80 26.70 5.70 18.00 3.75 18.80 -1.85 -3.70
3 CsA/GC Relapse 4.47 24.20 2.82 37.90 1.60 40.00 1.13 41.00 -3.34 16.80
4 cCTX/GC Resistant 4.00 25.30 2.65 37.50 0.56 46.10 1.28 47.00 -2.72 21.70
5 cCTX/GC Resistant 7.28 22.10 5.07 24.66 2.87 32.89 1.33 45.00 -5.95 22.90
6 TAC Intolerant 4.80 23.70 3.08 29.30 1.16 44.60 1.60 44.32 -3.20 20.62
7 TAC Intolerant 5.72 25.92 3.18 34.54 3.78 34.97 2.78 40.00 -2.94 14.08
8 CsA/GC Relapse 10.00 19.00 6.92 25.40 3.34 28.10 2.11 38.60 -7.89 19.60
9 cCTX/GC Resistant 6.17 24.00 4.58 30.40 1.63 46.60 0.17 47.36 -6.00 23.36
10 CsA/GC Relapse 3.10 27.10 1.45 43.00 0.23 49.00 0.21 49.00 -2.89 21.90
11 CsA/GC Relapse 5.10 24.50 2.00 44.50 1.80 41.40 1.13 45.00 -3.97 20.50
12 cCTX/GC Resistant 6.08 26.30 3.44 30.60 3.25 39.40 1.78 42.00 -4.30 15.70
13 CsA/GC Resistant 5.08 24.20 2.47 41.80 1.58 39.70 2.45 39.70 -2.63 15.50
14 cCTX/GC Relapse 4.20 23.70 6.80 14.80 6.20 14.50 3.30 21.80 -0.90 -1.90
15 CsA/GC Resistant 13.00 15.80 5.53 15.40 5.20 18.00 3.32 29.63 -9.68 13.83
Mean / / 5.93 23.88 3.94 30.45 3.01 34.23 1.99 38.96 -3.94 15.21
SD / / 2.54 3.28 1.78 9.47 2.02 11.69 1.17 9.08 2.48 8.48
Median / / 5.10 24.20 3.17 30.40 2.86 39.40 1.78 41.00 -3.20 16.80

Abbreviations. RMN: refectory membranous nephropathy; IST: immunosuppressive therapy; cCTX/GC: cyclical cyclophosphamide and steroids; TAC: tacrolimus; CsA/GC: cyclosporin and steroids.

aPaired t-test P<0.001 for 12-month change.